Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US8236799 | ALMIRALL | Biaryl compositions and methods for modulating a kinase cascade |
Dec, 2025
(2 years from now) | |
US8980890 | ALMIRALL | Compositions and methods of treating cell proliferation disorders |
Dec, 2025
(2 years from now) | |
US7300931 | ALMIRALL | Compositions for treating cell proliferation disorders |
Feb, 2026
(2 years from now) | |
US7851470 | ALMIRALL | Composition and methods for modulating a kinase cascade |
Feb, 2029
(5 years from now) | |
US10669236 | ALMIRALL | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide |
Sep, 2038
(15 years from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10323001 | ALMIRALL | Compositions for modulating a kinase cascade and methods of use thereof |
Dec, 2027
(4 years from now) | |
US10617693 | ALMIRALL | Methods of treating and/or preventing actinic keratosis |
Mar, 2038
(14 years from now) | |
US11497750 | ALMIRALL | Methods of treating and/or preventing actinic keratosis |
Mar, 2038
(14 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity (NCE) | Dec 14, 2025 |
NCE-1 date: 2024-12-14
Market Authorisation Date: 14 December, 2020
Treatment: Topical treatment of actinic keratosis of the face or scalp
Dosage: OINTMENT;TOPICAL
54
United States
12
Japan
9
China
6
Canada
6
Australia
6
European Union
4
Spain
4
Denmark
4
Korea, Republic of
4
Israel
4
Taiwan
3
Hong Kong
3
Russia
3
Brazil
2
Singapore
2
Cyprus
2
Mexico
1
Austria
1
Malaysia
1
Poland
1
Portugal
1
Netherlands
1
South Africa
1
Slovenia
1
Hungary
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic